Katja Weisel
Is this you? Claim this profileThis page collects the articles indexed under the name Katja Weisel. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.
Publications 2
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
- Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
Possible papers by Katja Weisel 4
Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.
-
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Same ORCID iD
-
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
-
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
Same name only
-
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Same name only
Under these spellings
-
Weisel K 2 articles
-
Katja C Weisel 1 article
-
Katja Christina Weisel 1 article
Same person? Claim this profile, then add these papers one by one or combine a whole spelling.
Is this you?
Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.
Institutions on these papers
- Universitätsklinikum Tübingen · DE 1
From OpenAlex, for papers with a DOI.